Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.Clinical toxicology (Philadelphia, Pa.) · 2026-06-22Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-08A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-06-04Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain modelsStanford Digital Repository · 2026-04-29A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary ExperimentsResearch Square · 2026-04-27The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.ClinicalTrials.gov · 2026-03-23Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-08The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-25Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-01The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.Current oncology (Toronto, Ont.) · 2025-12-21Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid rewardNature Communications · 2025-11-19Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot studyActa Neuropsychiatrica · 2025-11-03CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-10-31Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-04Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder AnalysisResearch Square · 2025-08-18Psilocybin triggers an activity-dependent rewiring of large-scale cortical networksbioRxiv · 2025-08-05Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.Unknown journal · 2025-07-31Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-07-14Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-03-28IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic painPharmacological Research · 2025-03-16Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.Unknown journal · 2025-02-17Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesPsyArXiv · 2025-02-12Clinical use of psilocybin in mental disorders:: a bibliometric analysis in Scopus and Web of ScienceDialnet (Universidad de la Rioja) · 2024-12-31Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.Unknown journal · 2024-12-08Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcomenpj Mental Health Research · 2024-10-05Identifying Three Psilocybin Use Patterns by Frequency and QuantityJournal of Studies on Alcohol and Drugs · 2024-08-22Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case reportFrontiers in Psychiatry · 2024-07-15Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility StudyClinicalTrials.gov · 2024-07-11Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”Frontiers in Psychiatry · 2024-06-03Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseasesUnknown journal · 2024-05-31The Classical Psychedelic Psilocybin Mitigates Oxycodone WithdrawalJournal of Pharmacology and Experimental Therapeutics · 2024-05-12Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.Unknown journal · 2024-04-05Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brainMolecular Psychiatry · 2024-02-19Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31P05-02: Assessment of the CYP450 inhibitory activity of psilocybin, psilocin, LSD, 5-MeO-DMT and mescaline: An in vitro studyToxicology Letters · 2023-08-31Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiencesScientific Reports · 2023-08-21Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-17High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybinbioRxiv · 2023-04-13Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-29Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)Toxicology Letters · 2022-08-31New Paradigms of Old Psychedelics in Schizophrenia.Unknown journal · 2022-05-22A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.Unknown journal · 2022-03-11Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.Unknown journal · 2022-03-03Selling the Priceless Mushroom: A History of Psilocybin Mushroom Trade in the Sierra Mazateca (Oaxaca)Journal of Illicit Economies and Development · 2021-12-31Psychedelic medicines for mood disorders: current evidence and clinical considerations.PubMed · 2021-12-31Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Magic mushroom: all is not as it seems.Acta chirurgica Belgica · 2021-09-30Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-18Psychedelics and health behaviour change.Unknown journal · 2021-05-28Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case StudiesmedRxiv · 2021-04-06Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)PsyArXiv · 2021-03-23Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.Australian & New Zealand Journal of Psychiatry · 2021-03-20A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.International Journal of Molecular Sciences · 2021-01-14Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pigEuropean Neuropsychopharmacology · 2020-12-03P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brainEuropean Neuropsychopharmacology · 2020-10-31Scalable Hybrid Synthetic/Biocatalytic Route to PsilocybinChemistry - A European Journal · 2020-02-25S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in “Magic” MushroomsChemBioChem · 2019-12-03Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.Unknown journal · 2019-05-31Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-01-25The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.Unknown journal · 2017-11-1914C-Psilocin tissue distribution in pregnant rats after intravenous administrationFunctional Foods in Health and Disease · 2014-07-26Psilocybin: Historical and pharmacological perspective and current authorized researchRepositorio Universidad de Caldas · 2008-12-31Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushroomsActa Toxicologica · 2002-12-31Patterns of recreational drug use at dance events in Edinburgh, Scotland.Unknown journal · 2001-06-30